nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—PTGS2—type 2 diabetes mellitus	0.167	1	CbGaD
Mefenamic acid—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0427	0.0797	CbGbCtD
Mefenamic acid—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0427	0.0797	CbGbCtD
Mefenamic acid—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0395	0.0735	CbGbCtD
Mefenamic acid—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0341	0.0636	CbGbCtD
Mefenamic acid—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0324	0.0604	CbGbCtD
Mefenamic acid—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0311	0.0579	CbGbCtD
Mefenamic acid—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0273	0.0508	CbGbCtD
Mefenamic acid—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0247	0.046	CbGbCtD
Mefenamic acid—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0238	0.0444	CbGbCtD
Mefenamic acid—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0228	0.0424	CbGbCtD
Mefenamic acid—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.022	0.041	CbGbCtD
Mefenamic acid—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0218	0.0406	CbGbCtD
Mefenamic acid—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0202	0.0377	CbGbCtD
Mefenamic acid—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0179	0.0334	CbGbCtD
Mefenamic acid—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0172	0.0321	CbGbCtD
Mefenamic acid—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0172	0.0321	CbGbCtD
Mefenamic acid—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0159	0.0296	CbGbCtD
Mefenamic acid—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0153	0.0286	CbGbCtD
Mefenamic acid—CYP2C9—Valsartan—type 2 diabetes mellitus	0.014	0.0261	CbGbCtD
Mefenamic acid—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.013	0.0243	CbGbCtD
Mefenamic acid—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0125	0.0233	CbGbCtD
Mefenamic acid—CYP2C8—Losartan—type 2 diabetes mellitus	0.0116	0.0215	CbGbCtD
Mefenamic acid—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00881	0.0164	CbGbCtD
Mefenamic acid—CYP2C9—Losartan—type 2 diabetes mellitus	0.00806	0.015	CbGbCtD
Mefenamic acid—AKR1C2—liver—type 2 diabetes mellitus	0.00163	0.103	CbGeAlD
Mefenamic acid—PTGS2—leg—type 2 diabetes mellitus	0.00147	0.0924	CbGeAlD
Mefenamic acid—PTGS2—hindlimb—type 2 diabetes mellitus	0.00131	0.0825	CbGeAlD
Mefenamic acid—AKR1C3—islet of Langerhans—type 2 diabetes mellitus	0.00114	0.0718	CbGeAlD
Mefenamic acid—AKR1C3—nephron tubule—type 2 diabetes mellitus	0.000918	0.0578	CbGeAlD
Mefenamic acid—PTGS1—artery—type 2 diabetes mellitus	0.000839	0.0529	CbGeAlD
Mefenamic acid—PTGS2—artery—type 2 diabetes mellitus	0.000802	0.0506	CbGeAlD
Mefenamic acid—AKR1C3—pancreas—type 2 diabetes mellitus	0.000801	0.0505	CbGeAlD
Mefenamic acid—AKR1C3—cortex of kidney—type 2 diabetes mellitus	0.000785	0.0495	CbGeAlD
Mefenamic acid—AKR1C3—adipose tissue—type 2 diabetes mellitus	0.000727	0.0458	CbGeAlD
Mefenamic acid—PTGS1—endothelium—type 2 diabetes mellitus	0.000709	0.0447	CbGeAlD
Mefenamic acid—PTGS2—endothelium—type 2 diabetes mellitus	0.000678	0.0427	CbGeAlD
Mefenamic acid—Acetylsalicylic acid—EDNRA—type 2 diabetes mellitus	0.00062	0.173	CrCbGaD
Mefenamic acid—AKR1C3—liver—type 2 diabetes mellitus	0.00051	0.0321	CbGeAlD
Mefenamic acid—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000385	0.0243	CbGeAlD
Mefenamic acid—CYP2C8—kidney—type 2 diabetes mellitus	0.000352	0.0222	CbGeAlD
Mefenamic acid—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000319	0.0201	CbGeAlD
Mefenamic acid—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000292	0.0184	CbGeAlD
Mefenamic acid—Floctafenine—PTGS2—type 2 diabetes mellitus	0.000289	0.0805	CrCbGaD
Mefenamic acid—Lumiracoxib—CYP1A2—type 2 diabetes mellitus	0.000287	0.08	CrCbGaD
Mefenamic acid—PTGS1—kidney—type 2 diabetes mellitus	0.000285	0.018	CbGeAlD
Mefenamic acid—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000279	0.0176	CbGeAlD
Mefenamic acid—PTGS2—kidney—type 2 diabetes mellitus	0.000273	0.0172	CbGeAlD
Mefenamic acid—PTGS2—pancreas—type 2 diabetes mellitus	0.000271	0.0171	CbGeAlD
Mefenamic acid—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000257	0.0162	CbGeAlD
Mefenamic acid—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000246	0.0155	CbGeAlD
Mefenamic acid—CYP2C8—liver—type 2 diabetes mellitus	0.000222	0.014	CbGeAlD
Mefenamic acid—CYP2C9—liver—type 2 diabetes mellitus	0.000198	0.0125	CbGeAlD
Mefenamic acid—Lumiracoxib—PTGS2—type 2 diabetes mellitus	0.000186	0.0518	CrCbGaD
Mefenamic acid—Tiaprofenic acid—PTGS2—type 2 diabetes mellitus	0.000186	0.0518	CrCbGaD
Mefenamic acid—Nepafenac—PTGS2—type 2 diabetes mellitus	0.000177	0.0493	CrCbGaD
Mefenamic acid—PTGS2—liver—type 2 diabetes mellitus	0.000172	0.0109	CbGeAlD
Mefenamic acid—Niflumic Acid—PTGS2—type 2 diabetes mellitus	0.000166	0.0462	CrCbGaD
Mefenamic acid—Salsalate—PTGS2—type 2 diabetes mellitus	0.000147	0.041	CrCbGaD
Mefenamic acid—Meclofenamic acid—PTGS2—type 2 diabetes mellitus	0.000145	0.0404	CrCbGaD
Mefenamic acid—Diclofenac—CYP2E1—type 2 diabetes mellitus	0.000131	0.0366	CrCbGaD
Mefenamic acid—Diclofenac—CYP1A2—type 2 diabetes mellitus	0.000125	0.0348	CrCbGaD
Mefenamic acid—Fenoprofen—PTGS2—type 2 diabetes mellitus	0.000122	0.0339	CrCbGaD
Mefenamic acid—Acetylsalicylic acid—PTGS2—type 2 diabetes mellitus	0.00011	0.0306	CrCbGaD
Mefenamic acid—Fenoprofen—ALB—type 2 diabetes mellitus	0.000108	0.0302	CrCbGaD
Mefenamic acid—Anorexia—Valsartan—type 2 diabetes mellitus	0.000105	0.000565	CcSEcCtD
Mefenamic acid—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000564	CcSEcCtD
Mefenamic acid—Malaise—Irbesartan—type 2 diabetes mellitus	0.000104	0.000563	CcSEcCtD
Mefenamic acid—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000104	0.000561	CcSEcCtD
Mefenamic acid—Headache—Pioglitazone—type 2 diabetes mellitus	0.000104	0.000561	CcSEcCtD
Mefenamic acid—Syncope—Irbesartan—type 2 diabetes mellitus	0.000104	0.00056	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000104	0.000559	CcSEcCtD
Mefenamic acid—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000103	0.000559	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000103	0.000557	CcSEcCtD
Mefenamic acid—Discomfort—Metformin—type 2 diabetes mellitus	0.000103	0.000557	CcSEcCtD
Mefenamic acid—Nausea—Glipizide—type 2 diabetes mellitus	0.000103	0.000555	CcSEcCtD
Mefenamic acid—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000103	0.000554	CcSEcCtD
Mefenamic acid—Hypotension—Valsartan—type 2 diabetes mellitus	0.000103	0.000554	CcSEcCtD
Mefenamic acid—Vision blurred—Losartan—type 2 diabetes mellitus	0.000103	0.000554	CcSEcCtD
Mefenamic acid—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000102	0.000552	CcSEcCtD
Mefenamic acid—Constipation—Gliclazide—type 2 diabetes mellitus	0.000102	0.000552	CcSEcCtD
Mefenamic acid—Tremor—Losartan—type 2 diabetes mellitus	0.000102	0.000551	CcSEcCtD
Mefenamic acid—Rash—Glimepiride—type 2 diabetes mellitus	0.000102	0.00055	CcSEcCtD
Mefenamic acid—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000102	0.000549	CcSEcCtD
Mefenamic acid—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000102	0.000549	CcSEcCtD
Mefenamic acid—Rash—Sitagliptin—type 2 diabetes mellitus	0.000101	0.000548	CcSEcCtD
Mefenamic acid—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000101	0.000547	CcSEcCtD
Mefenamic acid—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000101	0.000547	CcSEcCtD
Mefenamic acid—Headache—Glimepiride—type 2 diabetes mellitus	0.000101	0.000546	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000101	0.000545	CcSEcCtD
Mefenamic acid—Headache—Sitagliptin—type 2 diabetes mellitus	0.000101	0.000544	CcSEcCtD
Mefenamic acid—Anaemia—Losartan—type 2 diabetes mellitus	0.000101	0.000543	CcSEcCtD
Mefenamic acid—Oedema—Metformin—type 2 diabetes mellitus	0.0001	0.00054	CcSEcCtD
Mefenamic acid—Tinnitus—Ramipril—type 2 diabetes mellitus	9.99e-05	0.00054	CcSEcCtD
Mefenamic acid—Hypertension—Irbesartan—type 2 diabetes mellitus	9.98e-05	0.000539	CcSEcCtD
Mefenamic acid—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.96e-05	0.000538	CcSEcCtD
Mefenamic acid—Angioedema—Losartan—type 2 diabetes mellitus	9.94e-05	0.000537	CcSEcCtD
Mefenamic acid—Infection—Metformin—type 2 diabetes mellitus	9.93e-05	0.000536	CcSEcCtD
Mefenamic acid—Insomnia—Valsartan—type 2 diabetes mellitus	9.93e-05	0.000536	CcSEcCtD
Mefenamic acid—Paraesthesia—Valsartan—type 2 diabetes mellitus	9.86e-05	0.000532	CcSEcCtD
Mefenamic acid—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.85e-05	0.000532	CcSEcCtD
Mefenamic acid—Shock—Metformin—type 2 diabetes mellitus	9.84e-05	0.000531	CcSEcCtD
Mefenamic acid—Insomnia—Orlistat—type 2 diabetes mellitus	9.81e-05	0.00053	CcSEcCtD
Mefenamic acid—Malaise—Losartan—type 2 diabetes mellitus	9.81e-05	0.00053	CcSEcCtD
Mefenamic acid—Anxiety—Irbesartan—type 2 diabetes mellitus	9.81e-05	0.00053	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—ALB—type 2 diabetes mellitus	9.79e-05	0.0273	CrCbGaD
Mefenamic acid—Thrombocytopenia—Metformin—type 2 diabetes mellitus	9.79e-05	0.000529	CcSEcCtD
Mefenamic acid—Dyspnoea—Valsartan—type 2 diabetes mellitus	9.79e-05	0.000529	CcSEcCtD
Mefenamic acid—Vertigo—Losartan—type 2 diabetes mellitus	9.78e-05	0.000528	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	9.78e-05	0.000528	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.77e-05	0.000528	CcSEcCtD
Mefenamic acid—Somnolence—Valsartan—type 2 diabetes mellitus	9.76e-05	0.000527	CcSEcCtD
Mefenamic acid—Syncope—Losartan—type 2 diabetes mellitus	9.76e-05	0.000527	CcSEcCtD
Mefenamic acid—Paraesthesia—Orlistat—type 2 diabetes mellitus	9.74e-05	0.000526	CcSEcCtD
Mefenamic acid—Leukopenia—Losartan—type 2 diabetes mellitus	9.74e-05	0.000526	CcSEcCtD
Mefenamic acid—Discomfort—Irbesartan—type 2 diabetes mellitus	9.73e-05	0.000525	CcSEcCtD
Mefenamic acid—Skin disorder—Metformin—type 2 diabetes mellitus	9.71e-05	0.000525	CcSEcCtD
Mefenamic acid—Dyspepsia—Valsartan—type 2 diabetes mellitus	9.67e-05	0.000522	CcSEcCtD
Mefenamic acid—Dizziness—Bromocriptine—type 2 diabetes mellitus	9.63e-05	0.00052	CcSEcCtD
Mefenamic acid—Dry mouth—Irbesartan—type 2 diabetes mellitus	9.63e-05	0.00052	CcSEcCtD
Mefenamic acid—Palpitations—Losartan—type 2 diabetes mellitus	9.62e-05	0.000519	CcSEcCtD
Mefenamic acid—Nausea—Glimepiride—type 2 diabetes mellitus	9.59e-05	0.000518	CcSEcCtD
Mefenamic acid—Arrhythmia—Ramipril—type 2 diabetes mellitus	9.57e-05	0.000517	CcSEcCtD
Mefenamic acid—Loss of consciousness—Losartan—type 2 diabetes mellitus	9.56e-05	0.000516	CcSEcCtD
Mefenamic acid—Nausea—Sitagliptin—type 2 diabetes mellitus	9.56e-05	0.000516	CcSEcCtD
Mefenamic acid—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.55e-05	0.000516	CcSEcCtD
Mefenamic acid—Asthenia—Glyburide—type 2 diabetes mellitus	9.55e-05	0.000516	CcSEcCtD
Mefenamic acid—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.55e-05	0.000515	CcSEcCtD
Mefenamic acid—Anorexia—Metformin—type 2 diabetes mellitus	9.53e-05	0.000515	CcSEcCtD
Mefenamic acid—Urticaria—Gliclazide—type 2 diabetes mellitus	9.49e-05	0.000513	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	9.48e-05	0.000512	CcSEcCtD
Mefenamic acid—Alopecia—Ramipril—type 2 diabetes mellitus	9.47e-05	0.000511	CcSEcCtD
Mefenamic acid—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.45e-05	0.00051	CcSEcCtD
Mefenamic acid—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.45e-05	0.00051	CcSEcCtD
Mefenamic acid—Oedema—Irbesartan—type 2 diabetes mellitus	9.44e-05	0.00051	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	9.44e-05	0.00051	CcSEcCtD
Mefenamic acid—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.43e-05	0.000509	CcSEcCtD
Mefenamic acid—Pruritus—Glyburide—type 2 diabetes mellitus	9.42e-05	0.000509	CcSEcCtD
Mefenamic acid—Mental disorder—Ramipril—type 2 diabetes mellitus	9.39e-05	0.000507	CcSEcCtD
Mefenamic acid—Constipation—Valsartan—type 2 diabetes mellitus	9.39e-05	0.000507	CcSEcCtD
Mefenamic acid—Infection—Irbesartan—type 2 diabetes mellitus	9.37e-05	0.000506	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	9.37e-05	0.000506	CcSEcCtD
Mefenamic acid—Hypotension—Metformin—type 2 diabetes mellitus	9.34e-05	0.000505	CcSEcCtD
Mefenamic acid—Shock—Irbesartan—type 2 diabetes mellitus	9.28e-05	0.000501	CcSEcCtD
Mefenamic acid—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.26e-05	0.0005	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	9.24e-05	0.000499	CcSEcCtD
Mefenamic acid—Anxiety—Losartan—type 2 diabetes mellitus	9.23e-05	0.000499	CcSEcCtD
Mefenamic acid—Tachycardia—Irbesartan—type 2 diabetes mellitus	9.21e-05	0.000497	CcSEcCtD
Mefenamic acid—Rash—Bromocriptine—type 2 diabetes mellitus	9.18e-05	0.000496	CcSEcCtD
Mefenamic acid—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.17e-05	0.000495	CcSEcCtD
Mefenamic acid—Skin disorder—Irbesartan—type 2 diabetes mellitus	9.17e-05	0.000495	CcSEcCtD
Mefenamic acid—Tension—Ramipril—type 2 diabetes mellitus	9.16e-05	0.000494	CcSEcCtD
Mefenamic acid—Discomfort—Losartan—type 2 diabetes mellitus	9.15e-05	0.000494	CcSEcCtD
Mefenamic acid—Headache—Bromocriptine—type 2 diabetes mellitus	9.12e-05	0.000493	CcSEcCtD
Mefenamic acid—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.11e-05	0.000492	CcSEcCtD
Mefenamic acid—Nervousness—Ramipril—type 2 diabetes mellitus	9.06e-05	0.000489	CcSEcCtD
Mefenamic acid—Dry mouth—Losartan—type 2 diabetes mellitus	9.06e-05	0.000489	CcSEcCtD
Mefenamic acid—Salicylic acid—PTGS2—type 2 diabetes mellitus	9.05e-05	0.0252	CrCbGaD
Mefenamic acid—Anorexia—Irbesartan—type 2 diabetes mellitus	8.99e-05	0.000486	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.98e-05	0.000485	CcSEcCtD
Mefenamic acid—Paraesthesia—Metformin—type 2 diabetes mellitus	8.98e-05	0.000485	CcSEcCtD
Mefenamic acid—Confusional state—Losartan—type 2 diabetes mellitus	8.95e-05	0.000484	CcSEcCtD
Mefenamic acid—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.94e-05	0.000483	CcSEcCtD
Mefenamic acid—Dyspnoea—Metformin—type 2 diabetes mellitus	8.91e-05	0.000481	CcSEcCtD
Mefenamic acid—Somnolence—Metformin—type 2 diabetes mellitus	8.89e-05	0.00048	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.88e-05	0.00048	CcSEcCtD
Mefenamic acid—Oedema—Losartan—type 2 diabetes mellitus	8.88e-05	0.00048	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.87e-05	0.000479	CcSEcCtD
Mefenamic acid—Infection—Losartan—type 2 diabetes mellitus	8.82e-05	0.000476	CcSEcCtD
Mefenamic acid—Hypotension—Irbesartan—type 2 diabetes mellitus	8.82e-05	0.000476	CcSEcCtD
Mefenamic acid—Dyspepsia—Metformin—type 2 diabetes mellitus	8.8e-05	0.000475	CcSEcCtD
Mefenamic acid—Tremor—Ramipril—type 2 diabetes mellitus	8.74e-05	0.000472	CcSEcCtD
Mefenamic acid—Shock—Losartan—type 2 diabetes mellitus	8.74e-05	0.000472	CcSEcCtD
Mefenamic acid—Urticaria—Valsartan—type 2 diabetes mellitus	8.72e-05	0.000471	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Losartan—type 2 diabetes mellitus	8.69e-05	0.00047	CcSEcCtD
Mefenamic acid—Decreased appetite—Metformin—type 2 diabetes mellitus	8.69e-05	0.000469	CcSEcCtD
Mefenamic acid—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.68e-05	0.000469	CcSEcCtD
Mefenamic acid—Tachycardia—Losartan—type 2 diabetes mellitus	8.67e-05	0.000468	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	8.66e-05	0.000468	CcSEcCtD
Mefenamic acid—Nausea—Bromocriptine—type 2 diabetes mellitus	8.65e-05	0.000467	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	8.63e-05	0.000466	CcSEcCtD
Mefenamic acid—Urticaria—Orlistat—type 2 diabetes mellitus	8.62e-05	0.000466	CcSEcCtD
Mefenamic acid—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.58e-05	0.000463	CcSEcCtD
Mefenamic acid—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.58e-05	0.000463	CcSEcCtD
Mefenamic acid—Asthenia—Gliclazide—type 2 diabetes mellitus	8.57e-05	0.000463	CcSEcCtD
Mefenamic acid—Constipation—Metformin—type 2 diabetes mellitus	8.55e-05	0.000462	CcSEcCtD
Mefenamic acid—Angioedema—Ramipril—type 2 diabetes mellitus	8.53e-05	0.00046	CcSEcCtD
Mefenamic acid—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.47e-05	0.000458	CcSEcCtD
Mefenamic acid—Anorexia—Losartan—type 2 diabetes mellitus	8.46e-05	0.000457	CcSEcCtD
Mefenamic acid—Vomiting—Glyburide—type 2 diabetes mellitus	8.46e-05	0.000457	CcSEcCtD
Mefenamic acid—Pruritus—Gliclazide—type 2 diabetes mellitus	8.46e-05	0.000457	CcSEcCtD
Mefenamic acid—Malaise—Ramipril—type 2 diabetes mellitus	8.41e-05	0.000454	CcSEcCtD
Mefenamic acid—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.41e-05	0.000454	CcSEcCtD
Mefenamic acid—Rash—Glyburide—type 2 diabetes mellitus	8.39e-05	0.000453	CcSEcCtD
Mefenamic acid—Somnolence—Irbesartan—type 2 diabetes mellitus	8.39e-05	0.000453	CcSEcCtD
Mefenamic acid—Dermatitis—Glyburide—type 2 diabetes mellitus	8.38e-05	0.000453	CcSEcCtD
Mefenamic acid—Vertigo—Ramipril—type 2 diabetes mellitus	8.38e-05	0.000453	CcSEcCtD
Mefenamic acid—Syncope—Ramipril—type 2 diabetes mellitus	8.37e-05	0.000452	CcSEcCtD
Mefenamic acid—Leukopenia—Ramipril—type 2 diabetes mellitus	8.35e-05	0.000451	CcSEcCtD
Mefenamic acid—Headache—Glyburide—type 2 diabetes mellitus	8.34e-05	0.00045	CcSEcCtD
Mefenamic acid—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.31e-05	0.000449	CcSEcCtD
Mefenamic acid—Hypotension—Losartan—type 2 diabetes mellitus	8.3e-05	0.000448	CcSEcCtD
Mefenamic acid—Diclofenac—CYP3A4—type 2 diabetes mellitus	8.28e-05	0.0231	CrCbGaD
Mefenamic acid—Palpitations—Ramipril—type 2 diabetes mellitus	8.25e-05	0.000445	CcSEcCtD
Mefenamic acid—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.24e-05	0.000445	CcSEcCtD
Mefenamic acid—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.2e-05	0.000443	CcSEcCtD
Mefenamic acid—Loss of consciousness—Ramipril—type 2 diabetes mellitus	8.2e-05	0.000443	CcSEcCtD
Mefenamic acid—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.18e-05	0.000442	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.18e-05	0.000442	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	8.15e-05	0.00044	CcSEcCtD
Mefenamic acid—Diclofenac—PTGS2—type 2 diabetes mellitus	8.1e-05	0.0226	CrCbGaD
Mefenamic acid—Convulsion—Ramipril—type 2 diabetes mellitus	8.08e-05	0.000437	CcSEcCtD
Mefenamic acid—Constipation—Irbesartan—type 2 diabetes mellitus	8.07e-05	0.000436	CcSEcCtD
Mefenamic acid—Salicylic acid—ALB—type 2 diabetes mellitus	8.06e-05	0.0225	CrCbGaD
Mefenamic acid—Insomnia—Losartan—type 2 diabetes mellitus	8.03e-05	0.000434	CcSEcCtD
Mefenamic acid—Paraesthesia—Losartan—type 2 diabetes mellitus	7.97e-05	0.000431	CcSEcCtD
Mefenamic acid—Urticaria—Metformin—type 2 diabetes mellitus	7.94e-05	0.000429	CcSEcCtD
Mefenamic acid—Flurbiprofen—PTGS2—type 2 diabetes mellitus	7.93e-05	0.0221	CrCbGaD
Mefenamic acid—Dyspnoea—Losartan—type 2 diabetes mellitus	7.92e-05	0.000428	CcSEcCtD
Mefenamic acid—Anxiety—Ramipril—type 2 diabetes mellitus	7.92e-05	0.000428	CcSEcCtD
Mefenamic acid—Nausea—Glyburide—type 2 diabetes mellitus	7.91e-05	0.000427	CcSEcCtD
Mefenamic acid—Abdominal pain—Metformin—type 2 diabetes mellitus	7.9e-05	0.000427	CcSEcCtD
Mefenamic acid—Dizziness—Gliclazide—type 2 diabetes mellitus	7.9e-05	0.000427	CcSEcCtD
Mefenamic acid—Somnolence—Losartan—type 2 diabetes mellitus	7.89e-05	0.000426	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	7.89e-05	0.000426	CcSEcCtD
Mefenamic acid—Asthenia—Valsartan—type 2 diabetes mellitus	7.88e-05	0.000425	CcSEcCtD
Mefenamic acid—Discomfort—Ramipril—type 2 diabetes mellitus	7.85e-05	0.000424	CcSEcCtD
Mefenamic acid—Dyspepsia—Losartan—type 2 diabetes mellitus	7.82e-05	0.000422	CcSEcCtD
Mefenamic acid—Asthenia—Orlistat—type 2 diabetes mellitus	7.78e-05	0.00042	CcSEcCtD
Mefenamic acid—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.78e-05	0.00042	CcSEcCtD
Mefenamic acid—Pruritus—Valsartan—type 2 diabetes mellitus	7.77e-05	0.00042	CcSEcCtD
Mefenamic acid—Dry mouth—Ramipril—type 2 diabetes mellitus	7.77e-05	0.00042	CcSEcCtD
Mefenamic acid—Decreased appetite—Losartan—type 2 diabetes mellitus	7.72e-05	0.000417	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.72e-05	0.000417	CcSEcCtD
Mefenamic acid—Confusional state—Ramipril—type 2 diabetes mellitus	7.68e-05	0.000415	CcSEcCtD
Mefenamic acid—Pruritus—Orlistat—type 2 diabetes mellitus	7.68e-05	0.000415	CcSEcCtD
Mefenamic acid—Oedema—Ramipril—type 2 diabetes mellitus	7.61e-05	0.000411	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.61e-05	0.000411	CcSEcCtD
Mefenamic acid—Vomiting—Gliclazide—type 2 diabetes mellitus	7.6e-05	0.00041	CcSEcCtD
Mefenamic acid—Constipation—Losartan—type 2 diabetes mellitus	7.59e-05	0.00041	CcSEcCtD
Mefenamic acid—Rash—Gliclazide—type 2 diabetes mellitus	7.54e-05	0.000407	CcSEcCtD
Mefenamic acid—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.53e-05	0.000407	CcSEcCtD
Mefenamic acid—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.51e-05	0.000406	CcSEcCtD
Mefenamic acid—Urticaria—Irbesartan—type 2 diabetes mellitus	7.5e-05	0.000405	CcSEcCtD
Mefenamic acid—Shock—Ramipril—type 2 diabetes mellitus	7.49e-05	0.000405	CcSEcCtD
Mefenamic acid—Headache—Gliclazide—type 2 diabetes mellitus	7.49e-05	0.000404	CcSEcCtD
Mefenamic acid—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.46e-05	0.000403	CcSEcCtD
Mefenamic acid—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.46e-05	0.000403	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.46e-05	0.000403	CcSEcCtD
Mefenamic acid—Tachycardia—Ramipril—type 2 diabetes mellitus	7.43e-05	0.000401	CcSEcCtD
Mefenamic acid—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.42e-05	0.000401	CcSEcCtD
Mefenamic acid—Skin disorder—Ramipril—type 2 diabetes mellitus	7.4e-05	0.000399	CcSEcCtD
Mefenamic acid—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.32e-05	0.000395	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.26e-05	0.000392	CcSEcCtD
Mefenamic acid—Dizziness—Valsartan—type 2 diabetes mellitus	7.26e-05	0.000392	CcSEcCtD
Mefenamic acid—Anorexia—Ramipril—type 2 diabetes mellitus	7.26e-05	0.000392	CcSEcCtD
Mefenamic acid—Diclofenac—ALB—type 2 diabetes mellitus	7.22e-05	0.0201	CrCbGaD
Mefenamic acid—Ketoprofen—PTGS2—type 2 diabetes mellitus	7.18e-05	0.02	CrCbGaD
Mefenamic acid—Dizziness—Orlistat—type 2 diabetes mellitus	7.17e-05	0.000387	CcSEcCtD
Mefenamic acid—Asthenia—Metformin—type 2 diabetes mellitus	7.17e-05	0.000387	CcSEcCtD
Mefenamic acid—Hypotension—Ramipril—type 2 diabetes mellitus	7.12e-05	0.000384	CcSEcCtD
Mefenamic acid—Nausea—Gliclazide—type 2 diabetes mellitus	7.1e-05	0.000383	CcSEcCtD
Mefenamic acid—Pruritus—Metformin—type 2 diabetes mellitus	7.07e-05	0.000382	CcSEcCtD
Mefenamic acid—Flurbiprofen—ALB—type 2 diabetes mellitus	7.07e-05	0.0197	CrCbGaD
Mefenamic acid—Urticaria—Losartan—type 2 diabetes mellitus	7.05e-05	0.000381	CcSEcCtD
Mefenamic acid—Body temperature increased—Losartan—type 2 diabetes mellitus	7.02e-05	0.000379	CcSEcCtD
Mefenamic acid—Abdominal pain—Losartan—type 2 diabetes mellitus	7.02e-05	0.000379	CcSEcCtD
Mefenamic acid—Vomiting—Valsartan—type 2 diabetes mellitus	6.98e-05	0.000377	CcSEcCtD
Mefenamic acid—Rash—Valsartan—type 2 diabetes mellitus	6.92e-05	0.000374	CcSEcCtD
Mefenamic acid—Dermatitis—Valsartan—type 2 diabetes mellitus	6.92e-05	0.000374	CcSEcCtD
Mefenamic acid—Vomiting—Orlistat—type 2 diabetes mellitus	6.9e-05	0.000373	CcSEcCtD
Mefenamic acid—Insomnia—Ramipril—type 2 diabetes mellitus	6.89e-05	0.000372	CcSEcCtD
Mefenamic acid—Headache—Valsartan—type 2 diabetes mellitus	6.88e-05	0.000371	CcSEcCtD
Mefenamic acid—Diarrhoea—Metformin—type 2 diabetes mellitus	6.84e-05	0.000369	CcSEcCtD
Mefenamic acid—Rash—Orlistat—type 2 diabetes mellitus	6.84e-05	0.000369	CcSEcCtD
Mefenamic acid—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000369	CcSEcCtD
Mefenamic acid—Dermatitis—Orlistat—type 2 diabetes mellitus	6.83e-05	0.000369	CcSEcCtD
Mefenamic acid—Headache—Orlistat—type 2 diabetes mellitus	6.8e-05	0.000367	CcSEcCtD
Mefenamic acid—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.79e-05	0.000367	CcSEcCtD
Mefenamic acid—Asthenia—Irbesartan—type 2 diabetes mellitus	6.77e-05	0.000366	CcSEcCtD
Mefenamic acid—Somnolence—Ramipril—type 2 diabetes mellitus	6.77e-05	0.000366	CcSEcCtD
Mefenamic acid—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.7e-05	0.000362	CcSEcCtD
Mefenamic acid—Pruritus—Irbesartan—type 2 diabetes mellitus	6.68e-05	0.000361	CcSEcCtD
Mefenamic acid—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.62e-05	0.000357	CcSEcCtD
Mefenamic acid—Dizziness—Metformin—type 2 diabetes mellitus	6.61e-05	0.000357	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.57e-05	0.000355	CcSEcCtD
Mefenamic acid—Nausea—Valsartan—type 2 diabetes mellitus	6.52e-05	0.000352	CcSEcCtD
Mefenamic acid—Constipation—Ramipril—type 2 diabetes mellitus	6.51e-05	0.000352	CcSEcCtD
Mefenamic acid—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.46e-05	0.000349	CcSEcCtD
Mefenamic acid—Nausea—Orlistat—type 2 diabetes mellitus	6.44e-05	0.000348	CcSEcCtD
Mefenamic acid—Ketoprofen—ALB—type 2 diabetes mellitus	6.39e-05	0.0178	CrCbGaD
Mefenamic acid—Asthenia—Losartan—type 2 diabetes mellitus	6.37e-05	0.000344	CcSEcCtD
Mefenamic acid—Vomiting—Metformin—type 2 diabetes mellitus	6.36e-05	0.000343	CcSEcCtD
Mefenamic acid—Rash—Metformin—type 2 diabetes mellitus	6.3e-05	0.00034	CcSEcCtD
Mefenamic acid—Dermatitis—Metformin—type 2 diabetes mellitus	6.3e-05	0.00034	CcSEcCtD
Mefenamic acid—Pruritus—Losartan—type 2 diabetes mellitus	6.28e-05	0.000339	CcSEcCtD
Mefenamic acid—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000339	CcSEcCtD
Mefenamic acid—Headache—Metformin—type 2 diabetes mellitus	6.26e-05	0.000338	CcSEcCtD
Mefenamic acid—Dizziness—Irbesartan—type 2 diabetes mellitus	6.24e-05	0.000337	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000336	CcSEcCtD
Mefenamic acid—Diarrhoea—Losartan—type 2 diabetes mellitus	6.08e-05	0.000328	CcSEcCtD
Mefenamic acid—Urticaria—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000327	CcSEcCtD
Mefenamic acid—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000325	CcSEcCtD
Mefenamic acid—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000325	CcSEcCtD
Mefenamic acid—Vomiting—Irbesartan—type 2 diabetes mellitus	6e-05	0.000324	CcSEcCtD
Mefenamic acid—Rash—Irbesartan—type 2 diabetes mellitus	5.95e-05	0.000321	CcSEcCtD
Mefenamic acid—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.94e-05	0.000321	CcSEcCtD
Mefenamic acid—Nausea—Metformin—type 2 diabetes mellitus	5.94e-05	0.000321	CcSEcCtD
Mefenamic acid—Headache—Irbesartan—type 2 diabetes mellitus	5.91e-05	0.000319	CcSEcCtD
Mefenamic acid—Dizziness—Losartan—type 2 diabetes mellitus	5.87e-05	0.000317	CcSEcCtD
Mefenamic acid—Vomiting—Losartan—type 2 diabetes mellitus	5.65e-05	0.000305	CcSEcCtD
Mefenamic acid—Nausea—Irbesartan—type 2 diabetes mellitus	5.61e-05	0.000303	CcSEcCtD
Mefenamic acid—Rash—Losartan—type 2 diabetes mellitus	5.6e-05	0.000302	CcSEcCtD
Mefenamic acid—Dermatitis—Losartan—type 2 diabetes mellitus	5.59e-05	0.000302	CcSEcCtD
Mefenamic acid—Headache—Losartan—type 2 diabetes mellitus	5.56e-05	0.0003	CcSEcCtD
Mefenamic acid—Asthenia—Ramipril—type 2 diabetes mellitus	5.46e-05	0.000295	CcSEcCtD
Mefenamic acid—Pruritus—Ramipril—type 2 diabetes mellitus	5.39e-05	0.000291	CcSEcCtD
Mefenamic acid—Nausea—Losartan—type 2 diabetes mellitus	5.27e-05	0.000285	CcSEcCtD
Mefenamic acid—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.21e-05	0.000281	CcSEcCtD
Mefenamic acid—Dizziness—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000272	CcSEcCtD
Mefenamic acid—Vomiting—Ramipril—type 2 diabetes mellitus	4.84e-05	0.000261	CcSEcCtD
Mefenamic acid—Rash—Ramipril—type 2 diabetes mellitus	4.8e-05	0.000259	CcSEcCtD
Mefenamic acid—Dermatitis—Ramipril—type 2 diabetes mellitus	4.8e-05	0.000259	CcSEcCtD
Mefenamic acid—Headache—Ramipril—type 2 diabetes mellitus	4.77e-05	0.000258	CcSEcCtD
Mefenamic acid—Nausea—Ramipril—type 2 diabetes mellitus	4.52e-05	0.000244	CcSEcCtD
Mefenamic acid—PTGS1—Metabolism—CYP3A4—type 2 diabetes mellitus	9.73e-06	0.000106	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	9.7e-06	0.000105	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.69e-06	0.000105	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.68e-06	0.000105	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	9.61e-06	0.000105	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALDOB—type 2 diabetes mellitus	9.59e-06	0.000104	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—IL6—type 2 diabetes mellitus	9.57e-06	0.000104	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	9.57e-06	0.000104	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	9.57e-06	0.000104	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	9.57e-06	0.000104	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—SLC2A4—type 2 diabetes mellitus	9.56e-06	0.000104	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GCG—type 2 diabetes mellitus	9.56e-06	0.000104	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—SRC—type 2 diabetes mellitus	9.56e-06	0.000104	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	9.53e-06	0.000104	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.48e-06	0.000103	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	9.45e-06	0.000103	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	9.42e-06	0.000102	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOS1—type 2 diabetes mellitus	9.32e-06	0.000101	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	9.31e-06	0.000101	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	9.28e-06	0.000101	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	9.25e-06	0.000101	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	9.22e-06	0.0001	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	9.12e-06	9.92e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	9.06e-06	9.85e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.05e-06	9.84e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.05e-06	9.84e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	9.02e-06	9.8e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	9e-06	9.78e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GLP1R—type 2 diabetes mellitus	8.91e-06	9.69e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.9e-06	9.67e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	8.86e-06	9.63e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—AKT1—type 2 diabetes mellitus	8.83e-06	9.6e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	8.78e-06	9.55e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	8.76e-06	9.52e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	8.76e-06	9.52e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	8.76e-06	9.52e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.72e-06	9.48e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	8.64e-06	9.39e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	8.59e-06	9.34e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—TGFB1—type 2 diabetes mellitus	8.55e-06	9.29e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—RELA—type 2 diabetes mellitus	8.52e-06	9.26e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	8.52e-06	9.26e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	8.43e-06	9.16e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	8.42e-06	9.15e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	8.4e-06	9.13e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—EGFR—type 2 diabetes mellitus	8.38e-06	9.11e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	8.33e-06	9.06e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SLC2A2—type 2 diabetes mellitus	8.32e-06	9.04e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GNB3—type 2 diabetes mellitus	8.24e-06	8.96e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.24e-06	8.96e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—HMOX1—type 2 diabetes mellitus	8.2e-06	8.92e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—MTR—type 2 diabetes mellitus	8.15e-06	8.86e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CPT1A—type 2 diabetes mellitus	8.15e-06	8.86e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	8.14e-06	8.85e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	8.14e-06	8.85e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	8.14e-06	8.85e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	8.14e-06	8.85e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CAT—type 2 diabetes mellitus	8.1e-06	8.8e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	8.01e-06	8.71e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—NAMPT—type 2 diabetes mellitus	7.99e-06	8.69e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.95e-06	8.64e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	7.94e-06	8.63e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	7.94e-06	8.63e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	7.94e-06	8.63e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	7.92e-06	8.61e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	7.92e-06	8.61e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	7.89e-06	8.58e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	7.89e-06	8.57e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	7.86e-06	8.54e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	7.82e-06	8.51e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	7.8e-06	8.48e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	7.75e-06	8.43e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	7.72e-06	8.39e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.69e-06	8.35e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	7.66e-06	8.33e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	7.64e-06	8.31e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	7.64e-06	8.31e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	7.59e-06	8.25e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	7.59e-06	8.25e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.58e-06	8.24e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	7.5e-06	8.16e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APOB—type 2 diabetes mellitus	7.45e-06	8.1e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.42e-06	8.07e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—AKT1—type 2 diabetes mellitus	7.4e-06	8.04e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	7.35e-06	7.99e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.34e-06	7.98e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	7.32e-06	7.96e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.26e-06	7.9e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	7.25e-06	7.88e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.19e-06	7.81e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.15e-06	7.77e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	7.13e-06	7.75e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	7.12e-06	7.74e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	7.12e-06	7.74e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	7.12e-06	7.74e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—LPL—type 2 diabetes mellitus	7.11e-06	7.73e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	7.04e-06	7.65e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	6.99e-06	7.6e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	6.96e-06	7.57e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	6.93e-06	7.53e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.83e-06	7.43e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	6.78e-06	7.37e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	6.77e-06	7.36e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	6.76e-06	7.34e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.7e-06	7.29e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SRC—type 2 diabetes mellitus	6.7e-06	7.28e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	6.67e-06	7.26e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	6.63e-06	7.21e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	6.63e-06	7.21e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	6.63e-06	7.21e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CCR5—type 2 diabetes mellitus	6.55e-06	7.12e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.54e-06	7.11e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	6.54e-06	7.11e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.52e-06	7.09e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	6.52e-06	7.08e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	6.51e-06	7.08e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	6.51e-06	7.07e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.47e-06	7.03e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	6.46e-06	7.03e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	6.46e-06	7.03e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	6.46e-06	7.03e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	6.44e-06	7e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	6.44e-06	7e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—IL6—type 2 diabetes mellitus	6.44e-06	7e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	6.43e-06	6.99e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	6.42e-06	6.98e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	6.42e-06	6.98e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	6.4e-06	6.96e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	6.31e-06	6.86e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	6.31e-06	6.86e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	6.29e-06	6.84e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	6.28e-06	6.83e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.25e-06	6.8e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	6.24e-06	6.78e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	6.24e-06	6.78e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	6.22e-06	6.76e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.18e-06	6.72e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	6.18e-06	6.71e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	6.18e-06	6.71e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	6.11e-06	6.64e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IRS2—type 2 diabetes mellitus	6.09e-06	6.62e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	6.07e-06	6.6e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.99e-06	6.51e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CALM1—type 2 diabetes mellitus	5.98e-06	6.5e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APOE—type 2 diabetes mellitus	5.96e-06	6.48e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	5.96e-06	6.48e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—AKT1—type 2 diabetes mellitus	5.94e-06	6.46e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APOA1—type 2 diabetes mellitus	5.89e-06	6.41e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.87e-06	6.38e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	5.83e-06	6.34e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.82e-06	6.32e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	5.81e-06	6.32e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	5.8e-06	6.3e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	5.8e-06	6.3e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	5.8e-06	6.3e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	5.69e-06	6.19e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	5.66e-06	6.15e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	5.64e-06	6.13e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	5.59e-06	6.08e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.56e-06	6.05e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOS2—type 2 diabetes mellitus	5.56e-06	6.04e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	5.52e-06	6e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	5.48e-06	5.96e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—INS—type 2 diabetes mellitus	5.37e-06	5.84e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	5.36e-06	5.83e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	5.32e-06	5.79e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.32e-06	5.79e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IRS1—type 2 diabetes mellitus	5.32e-06	5.78e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	5.3e-06	5.76e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	5.3e-06	5.76e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	5.26e-06	5.72e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	5.24e-06	5.7e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	5.24e-06	5.7e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	5.23e-06	5.68e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	5.11e-06	5.56e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	5.1e-06	5.54e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—INS—type 2 diabetes mellitus	5.09e-06	5.54e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.09e-06	5.53e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	5.08e-06	5.52e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	5.03e-06	5.47e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	5.03e-06	5.47e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	5.01e-06	5.45e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	4.99e-06	5.43e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—AKT1—type 2 diabetes mellitus	4.98e-06	5.41e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	4.94e-06	5.37e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	4.94e-06	5.37e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	4.93e-06	5.36e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—AKT2—type 2 diabetes mellitus	4.92e-06	5.35e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	4.85e-06	5.27e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	4.75e-06	5.16e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	4.73e-06	5.14e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	4.71e-06	5.12e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.71e-06	5.12e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	4.68e-06	5.09e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	4.61e-06	5.01e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	4.55e-06	4.94e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL6—type 2 diabetes mellitus	4.51e-06	4.9e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	4.47e-06	4.86e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOS3—type 2 diabetes mellitus	4.47e-06	4.86e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	4.36e-06	4.74e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	4.35e-06	4.73e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.33e-06	4.71e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	4.33e-06	4.71e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	4.31e-06	4.69e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	4.31e-06	4.69e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	4.28e-06	4.65e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—INS—type 2 diabetes mellitus	4.27e-06	4.64e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	4.26e-06	4.63e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.16e-06	4.52e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	4.15e-06	4.51e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	4.13e-06	4.49e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	4.08e-06	4.43e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	4.06e-06	4.42e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	4.02e-06	4.37e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	4.02e-06	4.37e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.94e-06	4.29e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	3.91e-06	4.25e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.86e-06	4.2e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.85e-06	4.18e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.75e-06	4.07e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.74e-06	4.07e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	3.74e-06	4.07e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.7e-06	4.02e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.55e-06	3.86e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	3.54e-06	3.85e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.48e-06	3.79e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	3.47e-06	3.77e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.37e-06	3.67e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.32e-06	3.61e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.31e-06	3.59e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SRC—type 2 diabetes mellitus	3.3e-06	3.59e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.27e-06	3.55e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	3.18e-06	3.46e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	3.04e-06	3.31e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	3.04e-06	3.31e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	2.95e-06	3.21e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—EGFR—type 2 diabetes mellitus	2.9e-06	3.15e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.88e-06	3.13e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.82e-06	3.07e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.78e-06	3.03e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.59e-06	2.82e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.48e-06	2.69e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.48e-06	2.69e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.27e-06	2.46e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IL6—type 2 diabetes mellitus	2.23e-06	2.42e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	2.17e-06	2.35e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—AKT1—type 2 diabetes mellitus	2.05e-06	2.23e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	1.72e-06	1.87e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.4e-06	1.52e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.14e-06	1.24e-05	CbGpPWpGaD
